Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial-Reference-Cited by-全球学者库

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Published:2020-06 Issue:10240 Volume:395 Page:1845-1854
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Zhu Feng-Cai,Li Yu-Hua,Guan Xu-Hua,Hou Li-Hua,Wang Wen-Juan,Li Jing-Xin,Wu Shi-Po,Wang Bu-Sen,Wang Zhao,Wang Lei,Jia Si-Yue,Jiang Hu-Dachuan,Wang Ling,Jiang Tao,Hu Yi,Gou Jin-Bo,Xu Sha-Bei,Xu Jun-Jie,Wang Xue-Wen,Wang Wei,Chen Wei

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N Engl J Med,2020

2. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia;Li;N Engl J Med,2020

3. Compassionate use of remdesivir for patients with severe Covid-19;Grein;N Engl J Med,2020

4. Clinical course and mortality risk of severe COVID-19;Weiss;Lancet,2020

5. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study;Cowling;Lancet Public Health,2020

Cited by 1068 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Effects Post COVID-19 Vaccination and its Association with Age, Gender and Comorbid Disease in Basrah City Southern of Iraq;Current Drug Safety;2024-05

2. Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines;Autoimmunity Reviews;2024-03

3. Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses;Viruses;2024-02-02

4. High-Throughput Screening for the Prevalence of Neutralizing Antibodies against Human Adenovirus Serotype 5;Vaccines;2024-02-01

5. An adenovirus-vectored vaccine based on the N protein of feline coronavirus elicit robust protective immune responses;Antiviral Research;2024-02